REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,544,183 | +2.5% | 1,211,856 | -1.0% | 0.01% | +10.0% |
Q2 2023 | $32,734,649 | +34.5% | 1,223,725 | +8.9% | 0.01% | +25.0% |
Q1 2023 | $24,344,929 | +45.8% | 1,123,958 | +60.4% | 0.01% | +33.3% |
Q4 2022 | $16,694,000 | -14.7% | 700,923 | -29.4% | 0.01% | -14.3% |
Q3 2022 | $19,566,000 | +0.3% | 993,063 | -0.8% | 0.01% | 0.0% |
Q2 2022 | $19,500,000 | -21.2% | 1,001,308 | +3.2% | 0.01% | 0.0% |
Q1 2022 | $24,754,000 | +2.3% | 970,514 | +1.0% | 0.01% | 0.0% |
Q4 2021 | $24,196,000 | -8.3% | 961,296 | +0.2% | 0.01% | -12.5% |
Q3 2021 | $26,393,000 | -11.3% | 959,227 | +2.3% | 0.01% | -11.1% |
Q2 2021 | $29,740,000 | +54.3% | 937,485 | +123.2% | 0.01% | +50.0% |
Q1 2021 | $19,269,000 | +79.3% | 420,007 | +54.8% | 0.01% | +50.0% |
Q4 2020 | $10,744,000 | +513.9% | 271,325 | +440.1% | 0.00% | +300.0% |
Q3 2020 | $1,750,000 | +24.6% | 50,239 | +13.0% | 0.00% | 0.0% |
Q2 2020 | $1,404,000 | +0.9% | 44,444 | -30.0% | 0.00% | 0.0% |
Q1 2020 | $1,392,000 | – | 63,535 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |